CBU
PCVX icon

CIBC Bancorp USA’s Vaxcyte PCVX Stock Holding History

CIBC Bancorp USA’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$949K Buy
16,332
+2,324
+17% +$126K ﹤0.01% 1117
2026
Q1 		$814K Buy
+14,008
New +$760K ﹤0.01% 1087
2025
Q3 		$440K Buy
+12,205
New +$404K ﹤0.01% 922

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

CIBC Bancorp USA's PCVX Position: Q2 2026 in Review

CIBC Bancorp USA increased its Vaxcyte (PCVX) stake by 17% in Q2 2026, buying an estimated $126K and bringing the position to 16,332 shares worth $949K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

CIBC Bancorp USA first reported a position in PCVX in Q3 2025 and has held it in 3 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • CIBC Bancorp USA held 16,332 shares of Vaxcyte worth $949K as of Q2 2026.
  • CIBC Bancorp USA bought 2,324 Vaxcyte shares in Q2 2026, an estimated $126K.
  • Vaxcyte made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1117 holding.
  • CIBC Bancorp USA first reported a position in Vaxcyte in Q3 2025 and has held it in 3 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.